The Service of the Commission for the Protection of Competition has received from AI ICE & CY S.C.A. a notification of a concentration, according to Section 10 of the Control of Concentrations between Enterprises Law of 2014, concerning the acquisition of the share capital of ABC Farmaceutici S.p.A., via AI ICE & CY S.C.A..
Advent International Corporation is a private equity investor which focuses on managing investment funds and acquiring stakes in companies which are active in a variety of sectors, including operations and financial services, industrial products and services, retail activities, branded consumer and leisure products, media, telecommunications and information technology, and health and pharmaceutical services.
ICE is a company controlled by Advent, and is the parent company of the ICE group. ICE is mainly engaged in the production of Active Pharmaceutical Ingredients as well as their sale to pharmaceutical companies.
ABC is a joint-stock company which is active in the production, research and development, trading and sale of pharmaceutical products and active ingredients. ABC follows the entire supply chain of the drug, from the active ingredient to the manufacture of the final product and its promotion and sale.